Search results for "Atrophy"

showing 10 items of 385 documents

Differential associations of age with volume and microstructure of hippocampal subfields in healthy older adults

2015

Hippocampal atrophy in advanced healthy aging has frequently been reported. However, the vulnerability of different hippocampal subfields to age-related atrophy is still a source of debate. Moreover, the association of age with the microstructural integrity of subfields is largely unknown. In this study, we investigated the associations between age and volume as well as microstructural integrity of hippocampal subfields using a three-dimensional (3D) surface mapping approach. Forty-three healthy older adults spanning the age range from 60 to 85 years underwent T1-weighted and diffusion-tensor imaging. Analyses demonstrated an association of age with hippocampal volume predominantly in the m…

Radiological and Ultrasound TechnologySubiculumHippocampal formationmedicine.diseaseHippocampal atrophySurface mappingAtrophynervous systemNeurologymedicineHippocampal volumeRadiology Nuclear Medicine and imagingNeurology (clinical)AnatomyHealthy agingPsychologyNeuroscienceDiffusion MRIHuman Brain Mapping
researchProduct

Human NCL Neuropathology

2015

AbstractThe neuronal ceroid lipofuscinoses (NCL) currently encompass fourteen genetically different forms, CLN1 to CLN14, but are all morphologically marked by loss of nerve cells, particularly in the cerebral and cerebellar cortices, and the cerebral and extracerebral formation of lipopigments. These lipopigments show distinct ultrastructural patterns, i.e., granular, curvilinear/rectilinear and fingerprint profiles. They contain−although to a different degree among the different CLN forms−subunit C of ATP synthase, saposins A and D, and beta-amyloid proteins. Extracerebral pathology, apart from lipopigment formation, which provides diagnostic information, is scant or non-existent. The ret…

RetinaBatten diseaseLipopigmentsNeuropathologyAnatomyBiologymedicine.diseaseFingerprint profilesLysosomeAtrophymedicine.anatomical_structureNeuronal ceroid lipofuscinosesUltrastructureLysosomeNerve cellsmedicineImmunohistochemistryMolecular MedicineNeuroscienceMolecular BiologyNeuronal Ceroid-LipofuscinosesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
researchProduct

A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics

2011

Glutamate excitotoxicity leads to fragmented mitochondria in neurodegenerative diseases, mediated by nitric oxide and S-nitrosylation of dynamin-related protein 1, a mitochondrial outer membrane fission protein. Optic atrophy gene 1 (OPA1) is an inner membrane protein important for mitochondrial fusion. Autosomal dominant optic atrophy (ADOA), caused by mutations in OPA1, is a neurodegenerative disease affecting mainly retinal ganglion cells (RGCs). Here, we showed that OPA1 deficiency in an ADOA model influences N-methyl-D-aspartate (NMDA) receptor expression, which is involved in glutamate excitotoxicity and oxidative stress. Opa1enu/+mice show a slow progressive loss of RGCs, activation …

Retinal Ganglion CellsCancer ResearchReceptor expressionExcitotoxicityApoptosisNeurodegenerativeMitochondrionEyemedicine.disease_causeGTP PhosphohydrolasesMice0302 clinical medicineReceptorsoxidative stressPhosphorylationbcl-2-Associated X Protein0303 health sciencesbiologyGlutamate receptorMitochondriaUp-RegulationCell biologymitochondrial fusionAutosomal DominantOriginal Articlebcl-Associated Death ProteinMitochondrial fissionN-Methyl-D-AspartateBiotechnologymitochondrial fragmentationOncology and CarcinogenesisImmunologybcl-X ProteinSOD2Glutamic AcidReceptors N-Methyl-D-AspartateNMDA receptorsCell Line03 medical and health sciencesCellular and Molecular NeuroscienceBcl-2-associated X proteinOptic Atrophy Autosomal DominantmedicineAnimalsEye Disease and Disorders of Vision030304 developmental biologySuperoxide DismutaseNeurosciencesCell BiologyMolecular biologyeye diseasesOxidative StressOptic AtrophyMutationbiology.proteinOPA1 mutationBiochemistry and Cell Biologysense organsglutamate excitotoxicity030217 neurology & neurosurgeryCell Death & Disease
researchProduct

Retina in various animal models of neuronal ceroid-lipofuscinosis

1992

The childhood forms of human neuronal ceroid-lipofuscinosis (NCL) are invariably associated with a severe progressive retinopathy which commences at the photoreceptor level morphologically and proceeds to a final loss of neuronal cells accompanied by severe gliosis. In respective spontaneous animal conditions of NCL, in English setters, Dalmatian dogs, and New Zealand sheep, retinal involvement is not commensurate although the retina does not seem to be completely unaffected. In canine NCL, there might be functional and electro-physiological impairment of retinal cells, but retinal atrophy is not obvious. In ovine NCL, the retina, apart from accumulating NCL-specific lipopigments within neu…

Retinal degenerationPathologymedicine.medical_specialtyBiologyRetinachemistry.chemical_compoundDogsNeuronal Ceroid-LipofuscinosesmedicineCarnivoraAnimalsPigment Epithelium of EyeGenetics (clinical)RetinaSheepRetinal DegenerationRetinalPigments BiologicalAnatomymedicine.diseaseLipidseye diseasesRetinal atrophyDisease Models Animalmedicine.anatomical_structurechemistryGliosisNeuronal ceroid lipofuscinosissense organsmedicine.symptomRetinopathyAmerican Journal of Medical Genetics
researchProduct

Inactivity-induced oxidative stress: A central role in age-related sarcopenia?

2012

Ageing causes a progressive decline in skeletal muscle mass that may lead to decreased strength and functionality. The term sarcopenia is especially used to characterise this geriatric syndrome. Numerous conditions and behaviours are considered to accelerate the progression of sarcopenia such as chronic diseases, malnutrition and physical inactivity. As people in modern countries are more and more sedentary, the impact of physical inactivity on the prevalence of sarcopenia might be more and more important in the future. In this review, we discuss how reactive oxygen species (ROS) could mediate the effects of lifelong inactivity in the onset and progression of age-related sarcopenia. Althoug…

Sarcopeniamedicine.medical_specialty[SDV]Life Sciences [q-bio]Physical Therapy Sports Therapy and RehabilitationMotor ActivityBiologymedicine.disease_causeInternal medicinemedicineHumansOrthopedics and Sports MedicineAge-related sarcopeniaComputingMilieux_MISCELLANEOUSAgedAged 80 and over2. Zero hungerchemistry.chemical_classificationReactive oxygen speciesSkeletal muscleGeneral Medicinemedicine.diseaseMuscle atrophy3. Good healthMuscular AtrophyOxidative StressMalnutritionmedicine.anatomical_structureEndocrinologychemistryAgeingSarcopeniamedicine.symptomOxidative stressSignal TransductionEuropean Journal of Sport Science
researchProduct

Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals' perspective

2022

Abstract Objective Multiple sclerosis (MS) is a chronic disease with different clinical courses and a tendency to worsening. The relapsing–remitting MS presents acute onset and relapses of neurological symptoms, followed by their remission. This form can convert to secondary progressive MS (SPMS) with irreversible neurological worsening and disability. The identification of signs, symptoms, markers of progression, and strategies to manage MS patients is mandatory to allow early identification of those at higher risk of conversion to SPMS, for prompt intervention to cope with the progression of the disease. Methods A panel of Italian experts from Southern Italy have reviewed the current know…

Secondary progressive multiple sclerosis (SPMS)DermatologyGeneral MedicineBiomarkerMultiple Sclerosis Chronic ProgressiveMultiple sclerosisPsychiatry and Mental healthMultiple Sclerosis Relapsing-RemittingItalyExpert opinionDiagnosisQuality of LifeDisease ProgressionHumansMultiple sclerosiSettore MED/26 - NeurologiaNeurology (clinical)Neoplasm Recurrence LocalAtrophyDelivery of Health CareBiomarkersDiagnosi
researchProduct

Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey.

2022

ObjectiveSpinal muscular atrophy (SMA) is a neurodegenerative disorder caused by mutations in the SMN1 gene. The aim of this study was to assess the prevalence of SMA and treatment prescription in Italy.MethodsAn online survey was distributed to 36 centers identified by the Italian government as referral centers for SMA. Data on the number of patients with SMA subdivided according to age, type,SMN2copy number, and treatment were collected.ResultsOne thousand two hundred fifty-five patients with SMA are currently followed in the Italian centers with an estimated prevalence of 2.12/100,000. Of the 1,255, 284 were type I, 470 type II, 467 type III, and 15 type IV with estimated prevalence of 0…

Settore MED/39 - NEUROPSICHIATRIA INFANTILESettore MED/48 - SCIENZE INFERMIERISTICHE E TECNICHE NEURO-PSICHIATRICHE E RIABILITATIVEspinal muscular atrophy; smaepidemiologySettore MED/26 - NeurologiaNeurology (clinical)Spinal muscular atrophy (SMA) disease modifying therapies SMN1 SMN2 prevalenceITALIAN REGISTRYsmaSettore MED/42 - IGIENE GENERALE E APPLICATAPREVALENCEspinal muscular atrophyNeurology
researchProduct

Decreased motor unit firing rate and force control in older men

2006

Introduction Ageing is related to muscle atrophy that leads to decreases in muscle force. The largest changes are found in fast muscle fibres and fast force production, reducing the capability to recover from sudden balance disturbances. Also ageing-related decrease in force control has been found, as indicated by an increase in force fluctuations and motor unit (MU) firing variability (Galganski et al. 1993). Possibly due to differences in measurement protocols and muscles, the results concerning the effects of ageing on motor unit firing rate are, however, somewhat contradictory (for review, see Roos et al. 1997). The purpose of the present study was to investigate the age-related changes…

Soleus musclemedicine.medical_specialtyChemistryPhysical Therapy Sports Therapy and RehabilitationMuscle atrophyMotor unitPhysical medicine and rehabilitationMotor unit firing rateAgeingmedicinePhysical therapyOrthopedics and Sports Medicinemedicine.symptomBalance impairmentBalance (ability)Muscle forceJapanese Journal of Physical Fitness and Sports Medicine
researchProduct

Redox regulation of E3 ubiquitin ligases and their role in skeletal muscle atrophy

2015

Muscle atrophy is linked to reactive oxygen species (ROS) production during hindlimb-unloading due, at least in part, to the activation of xanthine oxidase (XO). The major aim of our study was to determine the mechanism by which ROS cause muscle atrophy and its possible prevention by allopurinol, a well-known inhibitor of XO widely used in clinical practice, and indomethacin, a nonsteroidal anti-inflammatory drug. We studied the activation of p38 MAP Kinase and NF-?B pathways, and the expression of two E3 ubiquitin ligases involved in proteolysis, the Muscle atrophy F-Box (MAFb) and Muscle RING Finger-1 (MuRF-1). Male Wistar rats (3 mold) conditioned by 14 days of hindlimb unloading (n=18),…

Soleus musclemedicine.medical_specialtySkeletal muscleAllopurinolHindlimbBiologymedicine.disease_causemedicine.diseaseBiochemistryMuscle atrophychemistry.chemical_compoundmedicine.anatomical_structureEndocrinologyAtrophychemistryBiochemistryPhysiology (medical)Internal medicinemedicinemedicine.symptomXanthine oxidaseOxidative stressmedicine.drugFree Radical Biology and Medicine
researchProduct

Phenotypic spectrum and incidence of TRPV4 mutations in patients with inherited axonal neuropathy.

2014

Objective: To clarify the phenotypic spectrum and incidence of TRPV4 mutations in patients with inherited axonal neuropathies. Methods: We screened for TRPV4 mutations in 169 French unrelated patients with inherited axonal peripheral neuropathy. Ninety-five patients had dominant Charcot-Marie-Tooth type 2 (CMT2) disease, and 74 patients, including 39 patients with distal hereditary motor neuropathy, 14 with congenital spinal muscular atrophy and arthrogryposis, 13 with CMT2, and 8 with scapuloperoneal spinal muscular atrophy, presented with additional vocal cord paralysis and/or skeletal dysplasia. Results: No deleterious TRPV4 mutation was identified in the 95 patients with “pure” CMT2 (0/…

TRPV4AdultMalePathologymedicine.medical_specialtyAdolescentTRPV Cation ChannelsYoung AdultMedicineMissense mutationHumansVocal cord paralysisHereditary Sensory and Autonomic NeuropathiesChildKyphoscoliosisAgedArthrogryposisbusiness.industryMusclesSpinal muscular atrophyMiddle Agedmedicine.diseasePhenotypeDysplasiaMutationFemaleNeurology (clinical)Francemedicine.symptomBone DiseasesbusinessAsymptomatic carrierNeurology
researchProduct